This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4r1y
From Proteopedia
(Difference between revisions)
m (Protected "4r1y" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 4r1y is ON HOLD | + | The entry 4r1y is ON HOLD until Paper Publication |
Authors: Blaukat, A., Bladt, F., Friese-Hamim, M., Knuehl, C., Fittschen, C., Graedler, U., Meyring, M., Dorsch, D., Stieber, F., Schadt, O. | Authors: Blaukat, A., Bladt, F., Friese-Hamim, M., Knuehl, C., Fittschen, C., Graedler, U., Meyring, M., Dorsch, D., Stieber, F., Schadt, O. | ||
Description: Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitor | Description: Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitor | ||
Revision as of 23:05, 1 October 2014
Unreleased structure
The entry 4r1y is ON HOLD until Paper Publication
Authors: Blaukat, A., Bladt, F., Friese-Hamim, M., Knuehl, C., Fittschen, C., Graedler, U., Meyring, M., Dorsch, D., Stieber, F., Schadt, O.
Description: Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitor
